CN107129470A - A kind of synthesis of minoxidil and process for purification - Google Patents

A kind of synthesis of minoxidil and process for purification Download PDF

Info

Publication number
CN107129470A
CN107129470A CN201710439588.4A CN201710439588A CN107129470A CN 107129470 A CN107129470 A CN 107129470A CN 201710439588 A CN201710439588 A CN 201710439588A CN 107129470 A CN107129470 A CN 107129470A
Authority
CN
China
Prior art keywords
minoxidil
synthesis
purification
crude product
condensation reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710439588.4A
Other languages
Chinese (zh)
Inventor
李光文
倪国成
李剑平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHANGZHOU TIANHUA PHARMACEUTICAL Co Ltd
Original Assignee
CHANGZHOU TIANHUA PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGZHOU TIANHUA PHARMACEUTICAL Co Ltd filed Critical CHANGZHOU TIANHUA PHARMACEUTICAL Co Ltd
Priority to CN201710439588.4A priority Critical patent/CN107129470A/en
Publication of CN107129470A publication Critical patent/CN107129470A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a kind of synthesis of minoxidil and process for purification, belong to the field of chemical synthesis.This method is with 2, the chlorine pyrimidine of 4 diaminourea 6 is that raw material obtains minoxidil crude product through low-temperature oxidation, base catalysis condition condensation two-step reaction, then recrystallized through polar solvent, the purification of the techniques such as activated carbon decolorizing obtains sterling minoxidil, sterling high purity 99.7% after refined, is a kind of preparation method easy to operate, being adapted to industrialized production.

Description

A kind of synthesis of minoxidil and process for purification
Technical field
The invention belongs to the field of chemical synthesis, it is related to synthesis and the process for purification of a kind of minoxidil, specifically this method Be with 2,4- diaminourea -6- chlorine pyrimidine be raw material it is oxidized, condensation two-step reaction obtain minoxidil crude product, then through being refining to obtain It is a kind of preparation method of suitable industrialized production to sterling minoxidil.
Background technology
Minoxidil also known as minoxidilum, minoxidil, chemical entitled 6- (1- piperidyls) -2,4- pyrimidinediamine -3- oxides, It is a kind of antihypertensive of potassium channels opening medicine, there is selectivity for angiectatic effect, with stronger drop Pressure is acted on, and is clinically generally used with other synthesis depressor compatibilities, for treating anxious Asia property and essential hypertension.Also simultaneously With the effect for promoting hair regeneration, local topical alopeciaing therapeutic is alternatively arranged as.
The synthetic method of current minoxidil only has a small amount of document report, is specifically following methods:
Using methyl cyanoacetate and guanidine nitrate as raw material, by cyclization, chlorination, oxidation, condensation four-step reaction with obtaining minot You, total recovery is 25.9%.But the guanidine nitrate that the method is used is raw material, and it easily explodes as explosive wastewater raw material, exist tight Weight potential safety hazard, it is impossible to realize industrialized production.
The content of the invention
The present invention be directed to synthesis and the process for purification that above-mentioned problem provides a kind of minoxidil.
The purpose of the present invention can be achieved through the following technical solutions:
A kind of synthesis of minoxidil and process for purification, it is characterised in that:This method is 2,4- diaminourea -6- chlorine pyrimidine warp Benzoyl hydroperoxide low-temperature oxidation obtains 6- amino -1,2- dihydro -1- hydroxyl -2- imino group -4- chlorine pyrimidines, and described 6- amino - 1,2- dihydro -1- hydroxyls -2- imino groups -4- chlorine pyrimidine carries out condensation reaction with hexahydropyridine in the condition that base catalyst is present, Obtain minoxidil crude product, after obtained crude product is dissolved by heating in a solvent add activated carbon decolorizing, filter, be dried to obtain it is pure Product minoxidil.
In technical solution of the present invention:The temperature of oxidation reaction is -15-25 DEG C.As preferred:The time of oxidation reaction is 2- 8h。
In technical solution of the present invention:Base catalyst used in condensation reaction is potassium carbonate, potassium hydroxide, sodium hydroxide and acetic acid At least one of sodium.As preferred:The temperature of condensation reaction is 40-120 DEG C.As preferred:The time of condensation reaction is 4- 12h。
In technical solution of the present invention:Solvent used in dissolving crude product is one kind or several in methanol, ethanol, acetone, acetonitrile Plant the mixing of solvent.
Beneficial effect:
This law has reaction condition gentle, and safe operation, reactions steps are few, convenient post-treatment, and product yield is high, by essence Purity is up to more than 99.5% after system.It is a kind of safety simple to operate, cost is low, be easy to the effective ways of industrialized production.
Embodiment
With reference to embodiment, the present invention will be further described, but protection scope of the present invention not limited to this.
Embodiment 1
6- amino -1,2- dihydro -1- hydroxyl -2- imino group -4- chlorine pyrimidine is synthesized
Weigh 2,4- diaminourea -6- chlorine pyrimidines (323g, 2.0mol, 1.0eq), dichloromethane (970mL) and be added to 2L's In four-hole boiling flask, stirring and dissolving clarification is cooled to -10 DEG C, adds benzoyl hydroperoxide (533g, 2.2mol, 1.1eq), stirring 15min, be then slowly added at -10 DEG C of temperature control 30% sodium hydrate aqueous solution (347g), then heat to 5 DEG C, insulation is anti- Answer 6h, TLC monitoring raw material disappearances (VDCM/MeOH=15:1) reaction, filtering, dry 6- amino -1,2- dihydro -1- hydroxyls, are stopped Base -2- imino group -4- chlorine pyrimidine 255g, yield is 79.4%, and it is 189 DEG C to determine fusing point, HPLC purity 97.3%,1H-NMR (d6-DMSO)δ:3.07 (s, 1H, OH) δ:6.08 (s, 1H, C-H), δ:7.54 (s, H, NH), δ:8.56 (s, 2H, NH2)。
Minoxidil is synthesized
Weigh 6- amino -1,2- dihydro -1- hydroxyl -2- imino group -4- chlorine pyrimidines (192.6g, 1.2mol, 1.0eq), 1, 4- dioxane (500mL) is added in 2L four-hole boiling flask, and dissolving clarification is stirred at room temperature, hexahydropyridine is then added (132.8g, 1.56mol, 1.3eq), potassium carbonate (216g, 1.56mol, 1.3eq), is warming up to 100 DEG C of reaction 4h, TLC monitoring former Material disappearance (VCHCl3/MeOH=10:1), stop reaction, be cooled to 5 DEG C, separate out solid, filtering produces minoxidil crude product 201g, Yield is 80.2%, and purity is 94.8%.
Minoxidil is refined
201g minoxidils crude product is added to 3000mL ethanol, heating is completely dissolved, cooled down, be added dropwise 3200 milliliters Water, is stirred at room temperature 1h, obtains faint yellow product;Filtering, drying.The minoxidils of 190g after purification are dissolved in 2500mL methanol In, after heating is completely dissolved, plus activated carbon decolorizing, filtering, 0 DEG C is cooled to, filtering, 50 DEG C of vacuum drying produce white solid Minoxidil highly finished product 172g, yield is 85.6%.Determine m.p:271 DEG C, purity 99.6%.
Embodiment 2
6- amino -1,2- dihydro -1- hydroxyl -2- imino group -4- chlorine pyrimidine is synthesized
Weigh 2,4- diaminourea -6- chlorine pyrimidines (582g, 3.6mol, 1.0eq), dichloromethane (1800mL) and be added to 5L's In four-hole boiling flask, stirring and dissolving clarification is cooled to -10 DEG C, adds benzoyl hydroperoxide (1046g, 4.32mol, 1.2eq), stirring 15min, be then slowly added at -10 DEG C of temperature control 30% sodium hydrate aqueous solution (720g), then heat to 15 DEG C, insulation is anti- Answer 4h, TLC monitoring raw material disappearances (VDCM/MeOH=15:1) reaction, filtering, dry 6- amino -1,2- dihydro -1- hydroxyls, are stopped Base -2- imino group -4- chlorine pyrimidine 492g, yield is 85.1%, and it is 190 DEG C to determine fusing point.
Minoxidil is synthesized
Weigh 6- amino -1,2- dihydro -1- hydroxyl -2- imino group -4- chlorine pyrimidines (192.6g, 1.2mol, 1.0eq), second Nitrile (400mL) is added in 1L four-hole boiling flask, be stirred at room temperature dissolving clarification, then add hexahydropyridine (153.3g, 1.80mol, 1.5eq), potassium hydroxide (100.8g, 1.80mol, 1.5eq), be warming up to 80 DEG C reaction 7h, TLC monitoring raw materials disappear Lose (VCHCl3/MeOH=10:1), stop reaction, be cooled to 5 DEG C, separate out solid, filtering produces minoxidil crude product 218.5g, received Rate is 87%, and purity is 96.1%.
Minoxidil is refined
218g minoxidils crude product is added to 1600mL acetonitrile and 400mL methanol, heating is completely dissolved, cooled down, drop Plus 2400 milliliters of water, 1h is stirred at room temperature, faint yellow product is obtained;Filtering, drying.The minoxidils of 209g after purification are dissolved in In 1500mL acetonitriles, after heating is completely dissolved, plus activated carbon decolorizing, filtering, 0 DEG C is cooled to, is filtered, 50 DEG C of vacuum drying, i.e., White solid minoxidil highly finished product 201g is obtained, yield is 92.2%.Determine m.p:272 DEG C, purity 99.7%.

Claims (7)

1. synthesis and the process for purification of a kind of minoxidil, it is characterised in that:This method is that 2,4- diaminourea -6- chlorine pyrimidine passes through Oxybenzoic acid low-temperature oxidation obtains 6- amino -1,2- dihydro -1- hydroxyl -2- imino group -4- chlorine pyrimidines, described 6- amino -1, 2- dihydros -1- hydroxyls -2- imino groups -4- chlorine pyrimidine carries out condensation reaction with hexahydropyridine in the condition that base catalyst is present, and obtains Activated carbon decolorizing is added to minoxidil crude product, after obtained crude product is dissolved by heating in a solvent, filters, be dried to obtain sterling Minoxidil.
2. synthesis and the process for purification of minoxidil according to claim 1, it is characterised in that:The temperature of oxidation reaction For -15-25 DEG C.
3. the synthesis of minoxidil according to claim 1 and refined method, it is characterised in that:The time of oxidation reaction For 2-8h.
4. synthesis and the process for purification of minoxidil according to claim 1, it is characterised in that:Alkali is urged used in condensation reaction Agent is at least one of potassium carbonate, potassium hydroxide, sodium hydroxide and sodium acetate.
5. synthesis and the process for purification of minoxidil according to claim 1, it is characterised in that:The temperature of condensation reaction is 40-120℃。
6. synthesis and the process for purification of minoxidil according to claim 1, it is characterised in that:The time of condensation reaction is 4-12h。
7. synthesis and the process for purification of minoxidil according to claim 1, it is characterised in that:It is molten used in dissolving crude product Agent be methanol, ethanol, acetone, acetonitrile in one or more of solvents mixing.
CN201710439588.4A 2017-06-12 2017-06-12 A kind of synthesis of minoxidil and process for purification Pending CN107129470A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710439588.4A CN107129470A (en) 2017-06-12 2017-06-12 A kind of synthesis of minoxidil and process for purification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710439588.4A CN107129470A (en) 2017-06-12 2017-06-12 A kind of synthesis of minoxidil and process for purification

Publications (1)

Publication Number Publication Date
CN107129470A true CN107129470A (en) 2017-09-05

Family

ID=59733909

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710439588.4A Pending CN107129470A (en) 2017-06-12 2017-06-12 A kind of synthesis of minoxidil and process for purification

Country Status (1)

Country Link
CN (1) CN107129470A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107987027A (en) * 2018-01-18 2018-05-04 天津药物研究院药业有限责任公司 A kind of minoxidil crystal, preparation method and the pharmaceutical composition containing this crystal
CN110272391A (en) * 2019-07-03 2019-09-24 天津药物研究院药业有限责任公司 A kind of refining methd of minoxidil
CN113979952A (en) * 2021-10-28 2022-01-28 昆明源瑞制药有限公司 Preparation method of minoxidil
CN114315738A (en) * 2022-01-15 2022-04-12 重庆东寰科技开发有限公司 Preparation method of 2,4-diaminopyrimidine-3-oxide
CN115572265A (en) * 2022-10-10 2023-01-06 江苏海悦康医药科技有限公司 Green synthesis process of high-purity minoxidil

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644364A (en) * 1970-03-31 1972-02-22 Upjohn Co Compounds and process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644364A (en) * 1970-03-31 1972-02-22 Upjohn Co Compounds and process

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107987027A (en) * 2018-01-18 2018-05-04 天津药物研究院药业有限责任公司 A kind of minoxidil crystal, preparation method and the pharmaceutical composition containing this crystal
CN110272391A (en) * 2019-07-03 2019-09-24 天津药物研究院药业有限责任公司 A kind of refining methd of minoxidil
CN110272391B (en) * 2019-07-03 2022-10-28 天津药物研究院药业有限责任公司 Refining method of minoxidil
CN113979952A (en) * 2021-10-28 2022-01-28 昆明源瑞制药有限公司 Preparation method of minoxidil
CN114315738A (en) * 2022-01-15 2022-04-12 重庆东寰科技开发有限公司 Preparation method of 2,4-diaminopyrimidine-3-oxide
CN114315738B (en) * 2022-01-15 2023-08-18 重庆东寰科技开发有限公司 Preparation method of 2,4-diaminopyrimidine-3-oxide
CN115572265A (en) * 2022-10-10 2023-01-06 江苏海悦康医药科技有限公司 Green synthesis process of high-purity minoxidil

Similar Documents

Publication Publication Date Title
CN107129470A (en) A kind of synthesis of minoxidil and process for purification
CN103435564B (en) A kind of preparation method of tebuconazole
CN109369545B (en) Synthesis process of 2-methyl-5-pyrazine formate
CN108623567A (en) Ao Si replaces the preparation method of Buddhist nun
JP7368636B2 (en) Method for synthesizing roxadustat and its intermediates and intermediates thereof
CN106279104B (en) A kind of process modification method preparing amber love song Ge Lieting
CN103554201A (en) Gamithromycin preparation method
CN105669642B (en) Preparation method of loflupridine hydrochloride
CN103819450A (en) Novel method for preparing alogliptin benzoate
CN106946887B (en) A kind of preparation method introducing catalyst optimization synthesis Dipyridamole
CN105461640A (en) Preparation method of tyrosine kinase inhibitor
CN107188888A (en) A kind of methanesulfonic acid for preparing steps the auspicious method for Buddhist nun
CN105237389A (en) Method for preparing hypolipidemic medicine ciprofibrate with p-coumaric acid
CN102127081A (en) Preparation method of adenine
CN107311946B (en) Synthetic method of 2- (1H-1,2, 3-triazolyl) -3-hydroxybiphenyl-4-carboxylic acid ethyl ester compound
CN104086456A (en) Synthesis method of sartanbiphenyl
CN103880717A (en) Preparation method of bis(3-allyl-4-hydroxy phenyl) sulfone and derivative thereof
CN113896732A (en) Preparation method and application of anti-cancer drug carbamatinib
CN101696185A (en) Synthesizing method of 6-nitro-S-(-)-indoline-2-carboxylic acid
CN107778314A (en) A kind of synthetic method of imidazopyridine derivatives
CN107698547A (en) A kind of preparation method of pyran derivate
CN114380832B (en) One-step synthesis method of guanine
CN107400106A (en) A kind of preparation method of 5- fluorine pyran derivate
CN110467567B (en) Preparation method of picoxystrobin
CN107663151B (en) Intermediate synthesis method of flumatinib mesylate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170905

RJ01 Rejection of invention patent application after publication